Human pluripotent stem cell derived midbrain PITX3eGFP/w neurons: a versatile tool for pharmacological screening and neurodegenerative modeling
Open Access
- 31 March 2015
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 9, 104
Abstract
PITX3 expression is confined to adult midbrain dopaminergic neurons. In this study we describe the generation and basic functional characteristics of midbrain dopaminergic neurons derived from a human pluripotent stem cell line expressing eGFP under the control of the PITX3 promoter. Flow cytometry shows that eGFP is evident in 15% of the neuron population at day 12 of differentiation and this level is maintained until at least day 80. From day 20-80 of differentiation intracellular chloride decreases and throughout this period around ~20% of PITX3eGFP/w neurons exhibit spontaneous Ca2+ transients (from 3.3+/-0.3 to 5.0+/-0.1 min-1, respectively). These neurons also respond to any of ATP, glutamate, acetylcholine or noradrenaline with elevations of intracellular calcium. As neuronal cultures mature more dopamine is released and single PITX3eGFP/w neurons begin to respond to more than one neurotransmitter. MPP+ and tumor necrosis factor(TNF), but not prostaglandin E2, caused death of the ~50% of PITX3eGFP/w neurons (day 80). Tracking eGFP using time lapse confocal microscopy over 24 hours demonstrated significant TNF-mediated neurite retraction over time. These PITX3eGFP/w neurons are amenable to flow cytometry, release dopamine and respond to multiple neurotransmitters with elevations of intracellular calcium, we believe that they represent a versatile system for neuropharmacological and neurotoxicological studies.Keywords
This publication has 55 references indexed in Scilit:
- Efficient Generation of A9 Midbrain Dopaminergic Neurons by Lentiviral Delivery of LMX1A in Human Embryonic Stem Cells and Induced Pluripotent Stem CellsHuman Gene Therapy, 2012
- What dopamine does in the brainProceedings of the National Academy of Sciences, 2011
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s diseaseNature, 2011
- Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusNature Communications, 2011
- LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative StressCell Stem Cell, 2011
- Delayed Dominant-Negative TNF Gene Therapy Halts Progressive Loss of Nigral Dopaminergic Neurons in a Rat Model of Parkinson's DiseaseMolecular Therapy, 2011
- Wnt1-lmx1a Forms a Novel Autoregulatory Loop and Controls Midbrain Dopaminergic Differentiation Synergistically with the SHH-FoxA2 PathwayCell Stem Cell, 2009
- Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleasesNature Biotechnology, 2009
- Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian ratsMolecular Therapy, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001